HCA HCA Healthcare, Inc. Common Stock
HCA Healthcare, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
और पढ़ें
HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
History
Early years
The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.
The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.
Growth and merger
The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.
In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.
In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,
to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.
Columbia Hospital Corporation
In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.
In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.
Recent history
On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.
In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.
In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.
In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.
In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.
In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.
In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.
In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.
Facilities
United States
As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.
Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.
In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.
In 2019 they purchased Mission Health System which operates hospitals in North Carolina.
In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.
In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.
United Kingdom
HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:
It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.
The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.
The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.
Significant areas of operation
Medical education
In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.
Controversies
Medicare billing practices lawsuit
In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.
The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.
2005 insider trading suit
In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.
COVID-19 PPE
During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.
Mission Hospital Acquisition Complaints
On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.
On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
HCA स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
HCA स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
| एक्स-डेट | राशि |
|---|---|
| 16 जून 2026 | $0.7800 |
| 17 मार्च 2026 | $0.7800 |
| 15 दिसमबर 2025 | $0.7200 |
| 16 सितमबर 2025 | $0.7200 |
| 16 जून 2025 | $0.7200 |
| 17 मार्च 2025 | $0.7200 |
| 13 दिसमबर 2024 | $0.6600 |
| 16 सितमबर 2024 | $0.6600 |
| 14 जून 2024 | $0.6600 |
| 14 मार्च 2024 | $0.6600 |
| 13 दिसमबर 2023 | $0.6000 |
| 14 सितमबर 2023 | $0.6000 |
| 15 जून 2023 | $0.6000 |
| 16 मार्च 2023 | $0.6000 |
| 13 दिसमबर 2022 | $0.5600 |
| 15 सितमबर 2022 | $0.5600 |
| 15 जून 2022 | $0.5600 |
| 16 मार्च 2022 | $0.5600 |
| 13 दिसमबर 2021 | $0.4800 |
| 15 सितमबर 2021 | $0.4800 |
HCA विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
- मजबूत खरीद 6 20.0%
- खरीदें 11 36.7%
- होल्ड 12 40.0%
- बेचें 1 3.3%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
21 विश्लेषक · 2026-08-17Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $7.62 | $7.54 | 0.08% |
| 31 मार्च 2026 | $7.15 | $7.21 | -0.06% |
| 31 दिसमबर 2025 | $8.14 | $7.53 | 0.61% |
| 30 सितमबर 2025 | $6.96 | $5.77 | 1.2% |
| 30 जून 2025 | $6.83 | $6.31 | 0.52% |
| 31 मार्च 2025 | $6.45 | $5.84 | 0.61% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | — |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | — |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | — |
| UHS | — | 9.4 | 9.7% | 8.6% | 21.4% | — |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | — |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | — |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | — |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 12
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
बैलेंस शीट 22
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
नकदी प्रवाह 17
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
लाभप्रदता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
दक्षता 2
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
विकास दरें 10
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 17
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
आय विवरण 12
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | -482,587,000 | 232,891,000 | 239,173,000 | 246,936,000 | -523,751,000 | 256,763,000 | 261,156,000 | 264,435,000 | -550,173,000 | 271,173,000 | 274,494,000 | 276,910,000 | -590,583,000 | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | -488,037,000 | 236,181,000 | 241,911,000 | 249,440,000 | -530,198,000 | 259,917,000 | 264,071,000 | 268,016,000 | -558,171,000 | 275,424,000 | 278,198,000 | 280,961,000 | -598,621,000 | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
बैलेंस शीट 20
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
नकदी प्रवाह 16
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
लाभप्रदता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
दक्षता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $77.11B | $75.20B | · | $73.57B | $71.91B | $70.64B | · | $68.53B | $66.91B | $65.00B | · | $62.64B | $61.24B | $60.33B | · | $60.01B | |
| Net Income TTM | $6.62B | $6.53B | · | $6.18B | $5.99B | $5.93B | · | $5.40B | $5.32B | $5.23B | · | $4.77B | $4.84B | $4.92B | · | $5.83B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.7 | 17.3 | · | 17.0 | 16.2 | 15.2 | · | 20.1 | 16.3 | 17.6 | · | 14.5 | 17.9 | 15.7 | · | 9.7 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.3 | 1.2 | · | 1.5 | 1.2 | 1.4 | · | 1.1 | 1.4 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| P / FCF | · | 117.7 | · | · | · | 127.2 | · | · | · | 65.0 | · | · | · | 120.1 | · | · | |
| EV / EBITDA | 135.0 | 154.7 | · | 152.3 | 149.4 | 148.2 | · | 170.5 | 150.6 | 159.4 | · | 136.0 | 158.5 | 146.5 | · | 118.7 | |
| EV / FCF | · | 160.7 | · | · | · | 193.1 | · | · | · | 93.8 | · | · | · | 182.8 | · | · | |
| EV / Revenue | 1.7 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Earnings Yield | 7.3% | 5.8% | · | 5.9% | 6.2% | 6.6% | · | 5.0% | 6.1% | 5.7% | · | 6.9% | 5.6% | 6.4% | · | 10.3% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| शुद्ध आय | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| तनुकरणित EPS | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| ऋण / इक्विटी | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| वर्तमान अनुपात | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| त्वरित अनुपात | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
- Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
- Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027
- HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
- गुरुवार की उल्लेखनीय ऑप्शन गतिविधि: HCA, HRTG, ZM
- HCA Healthcare (HCA) की फंडिंग रणनीति का विस्तार - यहाँ बताया गया है
- एचसीए हेल्थकेयर ने चिकित्सा देखभाल की मांग पर त्रैमासिक लाभ अनुमानों को पीछे छोड़ दिया
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 1485 फाइलर्स · $39.4B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 128 (-54 पिछली तिमाही की तुलना में) | 176 (+73 पिछली तिमाही की तुलना में) | 452 (-31 पिछली तिमाही की तुलना में) | 559 (-3 पिछली तिमाही की तुलना में) | +1.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6118113464 | 13104814 | 15.53% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $3954150533 | 10141708 | 10.04% | शेयर |
| Sanders Capital, LLC | $3442060818 | 8828287 | 8.74% | शेयर |
| STATE STREET CORP | $2912102056 | 7469035 | 7.39% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $1750298867 | 4489212 | 4.44% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $1225259672 | 3159159 | 3.11% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1057704509 | 2712828 | 2.68% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861456107 | 2209485 | 2.19% | शेयर |
| NORGES BANK | $836457140 | 2145367 | 2.12% | शेयर |
| Capital World Investors | $770864224 | 1977121 | 1.96% | शेयर |
| Capital International Investors | $747403041 | 1916947 | 1.90% | शेयर |
| Crake Asset Management LLP | $449072183 | 1151792 | 1.14% | शेयर |
| Metropolis Capital Ltd | $430915307 | 910564 | 1.09% | शेयर |
| Darsana Capital Partners LP | $428879000 | 1100000 | 1.09% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414533777 | 1063207 | 1.05% | शेयर |
| Life Cycle Investment Partners Ltd | $355737196 | 912404 | 0.90% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $339685814 | 871235 | 0.86% | शेयर |
| FMR LLC | $325199295 | 834080 | 0.83% | शेयर |
| BARCLAYS PLC | $299888573 | 769162 | 0.76% | शेयर |
| LYRICAL ASSET MANAGEMENT LP | $255015742 | 654071 | 0.65% | शेयर |
| BlackRock, Inc. | $240062291 | 615718 | 0.61% | शेयर |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235649908 | 604401 | 0.60% | शेयर |
| National Pension Service | $230650346 | 591578 | 0.59% | शेयर |
| NORDEA INVESTMENT MANAGEMENT AB | $230189125 | 594466 | 0.58% | शेयर |
| GOLDMAN SACHS GROUP INC | $209775669 | 538038 | 0.53% | शेयर |
| Gobi Capital LLC | $195742325 | 502045 | 0.50% | शेयर |
| Cryder Capital Partners LLP | $194561738 | 499017 | 0.49% | शेयर |
| Swiss National Bank | $172097446 | 441400 | 0.44% | शेयर |
| AustralianSuper Pty Ltd | $159635782 | 409438 | 0.41% | शेयर |
| Consulta Ltd | $155956000 | 400000 | 0.40% | शेयर |
| LEE DANNER & BASS INC | $152150679 | 390240 | 0.39% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $151472265 | 388500 | 0.38% | कॉल ऑप्शन |
| Mitsubishi UFJ Asset Management Co., Ltd. | $147943761 | 379450 | 0.38% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $139697405 | 358300 | 0.35% | शेयर |
| Vanguard Global Advisers, LLC | $136962509 | 351285 | 0.35% | शेयर |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $134838505 | 288820 | 0.34% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $134459788 | 284126 | 0.34% | शेयर |
| Sumitomo Mitsui Trust Group, Inc. | $132794974 | 340596 | 0.34% | शेयर |
| TD Asset Management Inc | $131847152 | 338165 | 0.33% | शेयर |
| Legal & General Group Plc | $127805162 | 327798 | 0.32% | शेयर |
| California Public Employees Retirement System | $124133958 | 318382 | 0.32% | शेयर |
| LAZARD ASSET MANAGEMENT LLC | $120619879 | 309369 | 0.31% | शेयर |
| JANE STREET GROUP, LLC | $119540274 | 306600 | 0.30% | कॉल ऑप्शन |
| VANGUARD ASSET MANAGEMENT, Ltd | $116069863 | 297699 | 0.29% | शेयर |
| CAPTRUST FINANCIAL ADVISORS | $114741071 | 294291 | 0.29% | शेयर |
| ANTIPODES PARTNERS Ltd | $113045096 | 289941 | 0.29% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $109718328 | 231845 | 0.28% | शेयर |
| CITADEL ADVISORS LLC | $105660190 | 271000 | 0.27% | कॉल ऑप्शन |
| RHUMBLINE ADVISERS | $97580413 | 250277 | 0.25% | शेयर |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $97026076 | 248855 | 0.25% | शेयर |
| MACKENZIE FINANCIAL CORP | $93597383 | 240061 | 0.24% | शेयर |
| BloombergSen Inc. | $93160317 | 238940 | 0.24% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $92247974 | 236600 | 0.23% | पुट ऑप्शन |
| Brandywine Global Investment Management, LLC | $89380814 | 191451 | 0.23% | शेयर |
| BANK OF AMERICA CORP /DE/ | $89069981 | 228449 | 0.23% | शेयर |
| NEUBERGER BERMAN GROUP LLC | $85926216 | 220386 | 0.22% | शेयर |
| MILFORD FUNDS LTD | $82165029 | 210739 | 0.21% | शेयर |
| Bridgewater Associates, LP | $79227208 | 203204 | 0.20% | शेयर |
| Prana Capital Management, LP | $75552494 | 193779 | 0.19% | शेयर |
| DANSKE BANK A/S | $73238497 | 187844 | 0.19% | शेयर |
| FRANKLIN RESOURCES INC | $70965828 | 182015 | 0.18% | शेयर |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $70445715 | 180681 | 0.18% | शेयर |
| Quantinno Capital Management LP | $70407055 | 180581 | 0.18% | शेयर |
| ARGENT CAPITAL MANAGEMENT LLC | $69149681 | 177357 | 0.18% | शेयर |
| Retirement Systems of Alabama | $68081812 | 174618 | 0.17% | शेयर |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $66167842 | 169709 | 0.17% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $64793090 | 166183 | 0.16% | शेयर |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $64665206 | 165855 | 0.16% | शेयर |
| HSBC HOLDINGS PLC | $64431534 | 165332 | 0.16% | शेयर |
| AVIVA PLC | $64264789 | 164828 | 0.16% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $64194533 | 135649 | 0.16% | शेयर |
| SEB Asset Management AB | $63257255 | 162244 | 0.16% | शेयर |
| TODD ASSET MANAGEMENT LLC | $62567208 | 160474 | 0.16% | शेयर |
| Swedbank AB | $62528998 | 160376 | 0.16% | शेयर |
| W1M Investment Management Ltd | $61247490 | 143647 | 0.16% | शेयर |
| HARRIS ASSOCIATES L P | $60080879 | 154097 | 0.15% | शेयर |
| Ensign Peak Advisors, Inc | $58372381 | 149715 | 0.15% | शेयर |
| NEW YORK STATE COMMON RETIREMENT FUND | $57747778 | 148113 | 0.15% | शेयर |
| CITADEL ADVISORS LLC | $57235852 | 146800 | 0.15% | पुट ऑप्शन |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57160993 | 146800 | 0.15% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $56512217 | 144944 | 0.14% | शेयर |
| Pictet Asset Management Holding SA | $52147803 | 133739 | 0.13% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $50752761 | 130172 | 0.13% | शेयर |
| Pentwater Capital Management LP | $50685700 | 130000 | 0.13% | शेयर |
| D. E. Shaw & Co., Inc. | $50554307 | 129663 | 0.13% | शेयर |
| APG Asset Management N.V. | $50368550 | 147699 | 0.13% | शेयर |
| AMF Tjanstepension AB | $50355853 | 129154 | 0.13% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $50349225 | 129137 | 0.13% | शेयर |
| EQUITABLE TRUST CO | $49147974 | 126056 | 0.12% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $48919124 | 125469 | 0.12% | शेयर |
| CANADA PENSION PLAN INVESTMENT BOARD | $48197812 | 123619 | 0.12% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $47460140 | 121727 | 0.12% | शेयर |
| OpenArc Corporate Advisory, LLC | $47210610 | 121087 | 0.12% | शेयर |
| L1 Capital International Pty Ltd | $46121648 | 118294 | 0.12% | शेयर |
| FIRST TRUST ADVISORS LP | $44251579 | 113498 | 0.11% | शेयर |
| PFA Pension, Forsikringsaktieselskab | $44046098 | 112971 | 0.11% | शेयर |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $43830264 | 112417 | 0.11% | शेयर |
| EP Wealth Advisors, LLC | $43287826 | 111026 | 0.11% | शेयर |
| WOLVERINE TRADING, LLC | $42597104 | 101200 | 0.11% | कॉल ऑप्शन |
| MERCER GLOBAL ADVISORS INC /ADV | $42302070 | 108497 | 0.11% | शेयर |
कंपनी के अंदरूनी सूत्र 91 इनसाइडर्स · 54 अधिकारी · 31 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10 फ़रवरी 2026 F | 64842 | 0 | 7 | $-21483290 |
| O'Boyle Michael P | President & CEO - Parallon | 26 फ़रवरी 2013 A | 21429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 7 मई 2026 G | 46576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16 फ़रवरी 2024 F | 22251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 1 जुलाई 2005 F | 13865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12 नवमबर 2024 M | 6843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31 जुलाई 2024 M | 27008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16 फ़रवरी 2024 F | 17936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11 नवमबर 2022 M | 202443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11 नवमबर 2022 S | 30807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31 दिसमबर 2012 A | 335657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 2 नवमबर 2011 M | 144714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26 जुलाई 2006 A | 62173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27 अक्टूबर 2005 A | 26154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31 अक्टूबर 2004 D | 9029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 7 मई 2004 D | 24177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10 फ़रवरी 2026 F | 23062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 13 फ़रवरी 2026 M | 8853 | 0 | 2 | $-2747520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11 फ़रवरी 2026 S | 11993 | 0 | 2 | $-4126932 |
| Christopher F. Wyatt | SVP & Controller | 11 फ़रवरी 2026 S | 44379 | 0 | 1 | $-2020000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10 फ़रवरी 2026 F | 10407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10 फ़रवरी 2026 F | 32080 | 0 | 1 | $-747135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13 फ़रवरी 2025 F | 11113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14 नवमबर 2024 S | 9454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12 नवमबर 2024 M | 52702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 5 अगस्त 2024 G | 18526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29 जुलाई 2024 S | 3510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 जुलाई 2024 S | 17755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 9 मई 2024 S | 5185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18 मार्च 2024 M | 1576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12 अप्रैल 2023 M | 24643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 9 नवमबर 2021 S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 5 मई 2021 S | 50062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18 फ़रवरी 2021 F | 5578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18 फ़रवरी 2021 F | 10122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 1 मई 2019 A | 194145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25 फ़रवरी 2019 M | 84157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25 फ़रवरी 2019 M | 881823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25 फ़रवरी 2018 M | 7003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25 फ़रवरी 2018 M | 35546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25 फ़रवरी 2018 M | 65199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23 मई 2017 M | 26378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 7 नवमबर 2016 M | 110167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25 फ़रवरी 2016 A | 51965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16 मई 2012 M | 299030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 6 अक्टूबर 2009 A | 188340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27 फ़रवरी 2009 M | 13092 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 4 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10 फ़रवरी 2026 | 31.60% | प्रारंभिक फाइलिंग | — | SEC |
| 22 नवमबर 2006 | — | प्रारंभिक फाइलिंग | — | SEC | |
| Merrill Lynch Bank USA | 11 सितमबर 2006 | — | प्रारंभिक फाइलिंग | — | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 4 अगस्त 2006 | — | प्रारंभिक फाइलिंग | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 208 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| BUL · Pacer Funds Trust | 3.91% | 11437 NS | 30 अप्रैल 2026 | N-PORT |
| YALL · Tidal Trust I | 3.61% | 9261 NS | 31 मई 2026 | N-PORT |
| BWTG · ETF Opportunities Trust | 3.02% | 1646 NS | 31 मई 2026 | N-PORT |
| ABIG · EA Series Trust | 2.00% | 2938 NS | 29 मई 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.99% | 39985 NS | 30 अप्रैल 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 1.64% | 688264 NS | 30 अप्रैल 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 1.64% | 1762 NS | 30 अप्रैल 2026 | N-PORT |
| PRAY · FIS Trust | 1.63% | 3480 NS | 31 मई 2026 | N-PORT |
| FEGE · RBB Fund Trust | 1.46% | 74706 NS | 31 मई 2026 | N-PORT |
| TMFE · RBB Fund, Inc. | 1.29% | 2892 NS | 31 मई 2026 | N-PORT |
| AMID · EA Series Trust | 1.23% | 3402 NS | 29 मई 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1.15% | 7180 NS | 30 अप्रैल 2026 | N-PORT |
| FMAG · FIDELITY COVINGTON TRUST | 1.12% | 6544 NS | 30 अप्रैल 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1.12% | 73639 NS | 30 अप्रैल 2026 | N-PORT |
| SRHQ · Elevation Series Trust | 1.10% | 4883 NS | 30 अप्रैल 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.98% | 3122 NS | 30 अप्रैल 2026 | N-PORT |
| PSET · Principal Exchange-Traded Funds | 0.88% | 652 NS | 30 जून 2026 | N-PORT |
| NFRA · FlexShares Trust | 0.88% | 62176 NS | 30 अप्रैल 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0.87% | 5693 NS | 30 अप्रैल 2026 | N-PORT |
| RXL · ProShares Trust | 0.86% | 1632 NS | 31 मई 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.81% | 285 NS | 30 अप्रैल 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.73% | 21329 NS | 30 अप्रैल 2026 | N-PORT |
| LCAP · Principal Exchange-Traded Funds | 0.71% | 33105 NS | 30 जून 2026 | N-PORT |
| RFFC · ALPS ETF Trust | 0.68% | 533 NS | 31 मई 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.68% | 2698 NS | 30 अप्रैल 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0.61% | 11771 NS | 30 अप्रैल 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0.58% | 72768 NS | 30 अप्रैल 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0.56% | 9664 NS | 31 मई 2026 | N-PORT |
| VLLU · Harbor ETF Trust | 0.54% | 54 NS | 30 अप्रैल 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.53% | 7404 NS | 30 अप्रैल 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0.51% | 844 NS | 30 अप्रैल 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 0.50% | 4620 NS | 31 मई 2026 | N-PORT |
| AKAF · ETF Series Solutions | 0.50% | 39 NS | 31 मई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.47% | 6388 NS | 30 अप्रैल 2026 | N-PORT |
| CGGR · Capital Group Growth ETF | 0.45% | 290273 NS | 31 मई 2026 | N-PORT |
| QLC · FlexShares Trust | 0.43% | 8820 NS | 30 अप्रैल 2026 | N-PORT |
| LGDX · Tidal Trust III | 0.41% | 1303 NS | 30 अप्रैल 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.38% | 12980 NS | 30 अप्रैल 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.37% | 4038 NS | 30 अप्रैल 2026 | N-PORT |
| TMFC · RBB Fund, Inc. | 0.34% | 18739 NS | 31 मई 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.31% | 3186 NS | 30 अप्रैल 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0.31% | 1526 NS | 31 मई 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0.29% | 51 NS | 31 मई 2026 | N-PORT |
| QARP · DBX ETF Trust | 0.27% | 529 NS | 29 मई 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.27% | 13332 NS | 30 अप्रैल 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.27% | 68 NS | 30 अप्रैल 2026 | N-PORT |
| SFGV · EA Series Trust | 0.25% | 7660 NS | 29 मई 2026 | N-PORT |
| MPLY · Strategy Shares | 0.25% | 75 NS | 30 अप्रैल 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0.24% | 1743 NS | 29 मई 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 0.24% | 257 NS | 30 अप्रैल 2026 | N-PORT |